- Home
- ARQT vs BTU Comparison
ARQT vs BTU Comparison
Compare ARQT & BTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- BTU
- Stock Information
- Founded
- ARQT 2016
- BTU 2016
- Country
- ARQT United States
- BTU United States
- Employees
- ARQT N/A
- BTU N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- BTU Coal Mining
- Sector
- ARQT Health Care
- BTU Energy
- Exchange
- ARQT Nasdaq
- BTU Nasdaq
- Market Cap
- ARQT 2.0B
- BTU 1.7B
- IPO Year
- ARQT 2020
- BTU N/A
- Fundamental
- Price
- ARQT $13.80
- BTU $12.63
- Analyst Decision
- ARQT Strong Buy
- BTU Strong Buy
- Analyst Count
- ARQT 6
- BTU 5
- Target Price
- ARQT $18.80
- BTU $24.60
- AVG Volume (30 Days)
- ARQT 2.6M
- BTU 6.9M
- Earning Date
- ARQT 05-13-2025
- BTU 05-01-2025
- Dividend Yield
- ARQT N/A
- BTU 2.45%
- EPS Growth
- ARQT N/A
- BTU N/A
- EPS
- ARQT N/A
- BTU 2.70
- Revenue
- ARQT $196,542,000.00
- BTU $4,236,700,000.00
- Revenue This Year
- ARQT $60.21
- BTU N/A
- Revenue Next Year
- ARQT $40.21
- BTU $11.96
- P/E Ratio
- ARQT N/A
- BTU $4.53
- Revenue Growth
- ARQT 229.74
- BTU N/A
- 52 Week Low
- ARQT $6.99
- BTU $9.61
- 52 Week High
- ARQT $17.75
- BTU $29.94
- Technical
- Relative Strength Index (RSI)
- ARQT 46.44
- BTU 48.75
- Support Level
- ARQT $12.51
- BTU $11.06
- Resistance Level
- ARQT $13.67
- BTU $12.91
- Average True Range (ATR)
- ARQT 1.43
- BTU 1.02
- MACD
- ARQT -0.27
- BTU 0.13
- Stochastic Oscillator
- ARQT 34.83
- BTU 72.77
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About BTU Peabody Energy Corporation
Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.